Radiprodil
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
UCB, Inc.
Mechanism of Action
Glutamate
Mechanism Description
Nr2B subtype selective NMRDA Receptor Antagonist
Populations Tested In
Infantile Spasms
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link